|
JAMA |
Addressing the Complex Driving Needs of an Aging Population |
1 |
Yes |
9/1/2026 |
|
JAMA Dermatology |
Adenopathy and an Extensive Skin Patch Overlying a Plasmacytoma Syndrome |
1 |
Yes |
12/20/2026 |
|
JAMA Cardiology |
Adenosine Triphosphate Citrate Lyase and Fatty Acid Synthesis Inhibition - A Narrative Review |
1 |
Yes |
8/16/2026 |
|
JAMA |
ADHD Pharmacotherapy and Mortality in Individuals With ADHD |
1 |
Yes |
3/12/2027 |
|
JAMA |
Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events - A Meta-Analysis |
1 |
Yes |
10/3/2026 |
|
JAMA Network Open |
Administration of AntiSARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization |
1 |
Yes |
9/2/2025 |
|
JAMA |
Adolescent-Centered Sexual and Reproductive Health Communication |
1 |
Yes |
12/18/2027 |
|
JAMA Cardiology |
Adult With Unrepaired Single-Ventricle Defect |
1 |
Yes |
9/6/2026 |
|
JAMA Oncology |
Advancing Global Pharmacoequity in Oncology |
1 |
Yes |
11/14/2027 |
|
JAMA Network Open |
Advancing Health Disparities Science Through Social Epigenomics Research |
1 |
Yes |
7/29/2027 |
|
AMA Journal of Ethics |
Advancing Health Equity by Avoiding Judgmentalism and Contextualizing Care |
1 |
Yes |
1/23/2027 |
|
JAMA Health Forum |
Advancing Health Policy and Outcomes for People With Intellectual or Developmental Disabilities - A Community-Led Agenda |
1 |
Yes |
8/2/2027 |
|
JAMA |
Age-Related Macular Degeneration - A Review |
1 |
Yes |
1/9/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
AI in Medicine: Cutting-Edge or Legal Landmine |
1 |
Yes |
9/22/2027 |
|
JAMA Cardiology |
Aligning US Agency Policies for Cardiovascular Devices Through the Breakthrough Devices Program |
1 |
Yes |
10/25/2026 |
|
JAMA Network Open |
All-Cause Maternal Mortality in the US Before vs During the COVID-19 Pandemic |
1 |
Yes |
8/1/2025 |
|
JAMA |
Allergic Rhinitis - A Review |
1 |
Yes |
3/12/2027 |
|
JAMA |
Allogeneic Stem Cell Donation |
1 |
Yes |
12/11/2027 |
|
JAMA Dermatology |
Alopecia Areata–Specific Patient-Reported Outcome Measures |
1 |
Yes |
3/5/2028 |
|
JAMA Neurology |
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis |
1 |
Yes |
8/14/2026 |
